Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Revenue

Rigel Pharmaceuticals had revenue of $58.82M in the quarter ending March 31, 2026, with 10.28% growth. This brings the company's revenue in the last twelve months to $299.77M, up 47.61% year-over-year. In the year 2025, Rigel Pharmaceuticals had annual revenue of $294.28M with 64.15% growth.

• Revenue (ttm): $299.77M
• Revenue Growth: +47.61%
• P/S Ratio: 1.98
• Revenue / Employee: $1,722,799
• Employees: 174
• Market Cap: 594.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	294.28M	115.00M	64.15%
Dec 31, 2024	179.28M	62.40M	53.38%
Dec 31, 2023	116.88M	-3.36M	-2.79%
Dec 31, 2022	120.24M	-28.99M	-19.43%
Dec 31, 2021	149.24M	40.62M	37.39%
Dec 31, 2020	108.62M	49.33M	83.21%
Dec 31, 2019	59.29M	14.78M	33.20%
Dec 31, 2018	44.51M	40.03M	892.62%
Dec 31, 2017	4.48M	-15.90M	-78.00%
Dec 31, 2016	20.38M	-8.51M	-29.46%
Dec 31, 2015	28.90M	20.65M	250.24%
Dec 31, 2014	8.25M	1.10M	15.38%
Dec 31, 2013	7.15M	4.90M	217.78%
Dec 31, 2012	2.25M	-2.50M	-52.63%
Dec 31, 2011	4.75M	-120.25M	-96.20%
Dec 31, 2010	125.00M	124.25M	16,566.67%
Dec 31, 2009	750.00K	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	12.60M	-20.87M	-62.36%
Dec 31, 2006	33.47M	16.95M	102.55%
Dec 31, 2005	16.53M	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 13, 2026

Data Sources Report a data error